Medical device maker, Abiomed's CEO, Michael Minogue, discusses his company's earnings beat, and whether the ultra expensive stock, selling for 5.8 times next year's sales, still has room to run, with Mad Money's Jim Cramer.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT